Use of Aloe Vera for Radiotherapy-Related Skin Reactions
Should aloe vera be used on the skin to prevent radiodermatitis?
Adverse Effect Management
Phase 2 Trial Assessed Feasibility of Enterade for Diarrhea Prevention After ASCT for MM or NHL
In a randomized study, researchers sought to determine patient adherence to diarrhea prevention with enterade among those undergoing ASCT for MM or NHL.
Dermatology Life Quality Index Valid for Assessing Radiodermatitis in Breast Cancer Patients
A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.
Etiology and Management of Nasopharyngeal Hemorrhage After Radiotherapy for Nasopharyngeal Carcinoma
[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
Toolbox Enables Quick Response to Anticancer Therapy-Induced Hypersensitivity Reactions
Researchers outline best practice for responding to anticancer therapy-induced hypersensitivity.
Quick Recognition of Adverse Effects Minimizes Discontinuations in Mogamulizumab Trial
A review of outcomes in the MAVORIC trial for patients with CTCL who experienced treatment-related AEs.
Addition of CHG-Impregnated Dressing Dramatically Changes CLABSI Rate
Including chlorhexidine gluconate-impregnated dressing in central line bundle resulted in a dramatic change in central line infections.
Patient Diaries Ensure Accurate Reports on Medication, Adverse Effects in Clinical Trial Participants
Patient-completed pill and toxicity diaries were linked to medication adherence and timely management of AEs in clinical trial participants.
Preparing Nurses for Possible Adverse Events with CAR-T Therapy
A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.
ePRO Tool Improves Symptom Management in an Outpatient Gynecologic Cancer Clinic
Investigators sought to determine if electronic patient-reported outcome tools with the PROMIS network improved identifying patients with severe symptoms and increased referrals to ancillary support services.
Next post in Gynecologic Cancer
